Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Articles
Articles
Two Dosing Schedules of Pembrolizumab for Patients with Advanced Melanoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Updated OS Data for the CA184-043 Trial: Immunotherapy with Ipilimumab Does Not Improve Survival in Patients with Metastatic Prostate Cancer
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Afatinib Improves Outcomes in Patients with Head and Neck Cancer
ESMO 2014 - Gastrointestinal and Head & Neck Cancer
,
ESMO
Conference Correspondent
Read More
Association of HPV and p16 Status with Cetuximab plus Radiotherapy in Locally Advanced Head and Neck Cancer
ESMO 2014 - Gastrointestinal and Head & Neck Cancer
,
ESMO
Conference Correspondent
Read More
Pembrolizumab in HPV-Positive Head and Neck Cancer
ESMO 2014 - Gastrointestinal and Head & Neck Cancer
,
ESMO
Conference Correspondent
Read More
Cetuximab, Fluorouracil, and Cisplatin, with/without Docetaxel, in Recurrent or Metastatic Head and Neck Cancer
ESMO 2014 - Gastrointestinal and Head & Neck Cancer
,
ESMO
Conference Correspondent
Read More
Anti–PD-L1 Monoclonal Antibody MPDL3280A in Metastatic Urothelial Bladder Cancer
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Long-Term Follow-Up Results of MPDL3280A in Metastatic Renal-Cell Carcinoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Dose-Ranging Phase 2 Results of Nivolumab Therapy in Metastatic Renal-Cell Carcinoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Pembrolizumab in the Treatment of Patients with Advanced Urothelial Tract Cancer
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Page 214 of 329
211
212
213
214
215
216
217
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma